100 results
424B3
PASG
Passage Bio Inc
14 May 24
Prospectus supplement
8:15am
for enhanced benefits due to widespread vector delivery to the brain and spinal cord, and an improved safety profile compared with systemic administration … the rigorous capsid and transgene selection process, and our chosen route of ICM administration, which provides the potential for enhanced benefits due
8-K
EX-99.2
PASG
Passage Bio Inc
14 May 24
Passage Bio Reports First Quarter 2024 Financial Results and Provides Recent Business Highlights
7:01am
expected into 4Q 2025* Exploring benefits of elevated progranulin in multiple adult neurodegenerative diseases * Based on cash, cash equivalents … to support program execution Strong cash position with runway expected into 4Q 2025* Exploring benefits of elevated progranulin in multiple adult
S-3
EX-4.4
PASG
Passage Bio Inc
4 Mar 24
Shelf registration
4:09pm
of Securities shall be equally and ratably entitled to the benefits of the Indenture.
2.2. ESTABLISHMENT OF TERMS OF SERIES OF SECURITIES.
At or prior … of the Company, evidencing the same debt, and entitled to the same benefits under this Indenture, as the Securities surrendered upon such registration
S-3
1q5ntfsb5vail8oycz
4 Mar 24
Shelf registration
4:09pm
8-K
EX-99.1
y1sledql
29 Dec 23
In the Court of Chancery of the State of Delaware
4:15pm
8-K
EX-99.2
evywy1xw
13 Nov 23
Passage Bio Reports Third Quarter 2023 Financial Results and Provides Recent Business Highlights
7:00am
8-K
EX-99.1
sk1t z80aczogi
11 May 23
Passage Bio Reports First Quarter 2023 Financial Results and Provides Recent Business Highlights
7:09am
8-K
EX-99.2
lxdqh
11 May 23
Passage Bio Reports First Quarter 2023 Financial Results and Provides Recent Business Highlights
7:09am